Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.

Cueva JF, Antolín S, Calvo L, Fernández I, Ramos M, de Paz L, Mata JG, López R, Constenla M, Pérez E, González A, Pellón ML, Varela S, López T.

Clin Transl Oncol. 2017 Sep;19(9):1067-1078. doi: 10.1007/s12094-017-1648-8. Epub 2017 Mar 24.

PMID:
28342058
2.

Development of different diagnostic techniques for Endolimax piscium (archamoebae) and their applicability in Solea senegalensis clinical samples.

Constenla M, Padrós F, Del Pozo R, Palenzuela O.

J Fish Dis. 2016 Dec;39(12):1433-1443. doi: 10.1111/jfd.12480. Epub 2016 Jun 3.

PMID:
27260115
3.

Comparative Study of Survival following Videothoracoscopic Lobectomy Procedures for Lung Cancer: Single- versus Multiple-port Approaches.

Borro JM, Regueiro F, Pértega S, Constenla M, Pita S.

Arch Bronconeumol. 2017 Apr;53(4):199-205. doi: 10.1016/j.arbres.2016.06.018. Epub 2016 Sep 7. English, Spanish.

4.

147P: Level of concordance between EGFR mutation status obtained from tissue/cytology and blood (plasma) for advanced non-small-cell lung cancer in Spain: ASSESS study.

Arriola E, Paredes A, Gomez RG, Diz P, Constenla M, Girón CG, Amador M, Reck M, Vivanco GL.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S122. doi: 10.1016/S1556-0864(16)30257-X. Epub 2016 Apr 15. No abstract available.

5.

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.

Martínez-López J, Paiva B, López-Anglada L, Mateos MV, Cedena T, Vidríales MB, Sáez-Gómez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordón L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Bladé J, San Miguel JF, Lahuerta JJ; Spanish Multiple Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Group.

Blood. 2015 Aug 13;126(7):858-62. doi: 10.1182/blood-2015-04-638742. Epub 2015 Jun 18.

6.

Raphidascaris (Raphidascaris) macrouri n. sp. (Nematoda: Anisakidae) from two deep-sea macrourid fishes in the Western Mediterranean: Morphological and molecular characterisations.

Pérez-i-García D, Constenla M, Carrassón M, Montero FE, Soler-Membrives A, González-Solís D.

Parasitol Int. 2015 Oct;64(5):345-52. doi: 10.1016/j.parint.2015.05.002. Epub 2015 May 12.

PMID:
25979612
7.

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

Martín M, Martínez N, Ramos M, Calvo L, Lluch A, Zamora P, Muñoz M, Carrasco E, Caballero R, García-Sáenz JÁ, Guerra E, Caronia D, Casado A, Ruíz-Borrego M, Hernando B, Chacón JI, De la Torre-Montero JC, Jimeno MÁ, Heras L, Alonso R, De la Haba J, Pita G, Constenla M, González-Neira A.

Oncologist. 2015 Feb;20(2):111-2. doi: 10.1634/theoncologist.2014-0379. Epub 2015 Jan 19.

8.

Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy.

Esquerdo G, Doménech M, López P, Pedro C, Villadiego K, Constenla M, Sánchez-Rovira P, Gasquet JA, Rodríguez CA; AVANT study group.

Tumori. 2014 Mar-Apr;100(2):225-31. doi: 10.1700/1491.16423.

PMID:
24852870
9.

Endolimax piscium sp. nov. (Amoebozoa), causative agent of systemic granulomatous disease of cultured sole, Solea senegalensis Kaup.

Constenla M, Padrós F, Palenzuela O.

J Fish Dis. 2014 Mar;37(3):229-40. doi: 10.1111/jfd.12097. Epub 2013 Mar 18.

PMID:
23496286
10.

Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer.

Carrato A, Gómez A, Escudero P, Chaves M, Rivera F, Marcuello E, González E, Grávalos C, Constenla M, Manzano JL, Losa F, Maurel J, Dueñas R, Massuti B, Gallego J, Aparicio J, Antón A, Aranda E.

Clin Transl Oncol. 2013 Sep;15(9):705-11. doi: 10.1007/s12094-012-0993-x. Epub 2013 Jan 29.

PMID:
23359181
11.

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.

Provencio M, Sánchez A, Artal A, Sánchez Torres JM, García Gómez R, Constenla M, de Castro J, Dómine M, Viñolas N, Sánchez A, Pérez FJ.

Clin Transl Oncol. 2013 Aug;15(8):659-64. doi: 10.1007/s12094-012-0989-6. Epub 2013 Jan 29. Erratum in: Clin Transl Oncol. 2013 Aug;15(8):670. García Gómez, Ramón [added]; Constenla, Manuel [added].

PMID:
23359178
12.

Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.

Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Reboredo M, Manzano JL, Rivera F, Safont MJ, Montagut C, González E, Benavides M, Marcuello E, Cervantes A, Martínez de Prado P, Fernández-Martos C, Arrivi A, Bando I, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

PLoS One. 2012;7(10):e47345. doi: 10.1371/journal.pone.0047345. Epub 2012 Oct 12.

13.

Pain in clinical oncology: patient satisfaction with management of cancer pain.

Antón A, Montalar J, Carulla J, Jara C, Batista N, Camps C, Cassinello J, Sanz-Ortiz J, Díaz-Rubio E, Martínez C, Ledesma F, Zubillaga E; ALGOS Group; DOME III Study Group.

Eur J Pain. 2012 Mar;16(3):381-9. doi: 10.1002/j.1532-2149.2011.00036.x. Epub 2011 Dec 23.

14.

Parasitisation by Bathycreadium elongatum (Digenea, Opecoelidae) in pyloric caeca of Trachyrincus scabrus (Teleostei, Macrouridae).

Constenla M, Carrassón M, Moyà CM, Fernàndez-Chacón A, Padrós F, Repullés-Albelda A, Montero FE.

Dis Aquat Organ. 2011 Oct 6;96(3):239-47. doi: 10.3354/dao02393.

15.

Adjuvant docetaxel for high-risk, node-negative breast cancer.

Martín M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A; GEICAM 9805 Investigators.

N Engl J Med. 2010 Dec 2;363(23):2200-10. doi: 10.1056/NEJMoa0910320.

16.

Histopathological and ultrastructural studies on a novel pathological condition in Solea senegalensis.

Constenla M, Padrós F.

Dis Aquat Organ. 2010 Jul 1;90(3):191-6. doi: 10.3354/dao02233.

17.

The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.

Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Clack G, Bianco AR; ATAC Trialists' Group.

J Obstet Gynaecol. 2010;30(6):596-604. doi: 10.3109/01443615.2010.492433.

PMID:
20701510
18.

Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer.

Roca JM, Alonso V, Pericay C, Escudero P, Salud A, Losa F, López LJ, Guasch I, Méndez M, Quintero-Aldana G, Grande C, Vicente P, Arrivi A, Martin C, Moreno I, García P, Antón I, Constenla M, Yubero A, Cirera L; ACROSS Cooperative Group.

Chemotherapy. 2010;56(2):142-6. doi: 10.1159/000313527. Epub 2010 Apr 21.

PMID:
20407241
19.

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.

Schwenkglenks M, Pettengell R, Jackisch C, Paridaens R, Constenla M, Bosly A, Szucs TD, Leonard R.

Support Care Cancer. 2011 Apr;19(4):483-90. doi: 10.1007/s00520-010-0840-y. Epub 2010 Mar 20.

PMID:
20306092
20.

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team.

Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9.

PMID:
19410716

Supplemental Content

Loading ...
Support Center